Kazuhiro Shibayama

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

Hiroyoshi Suzuki, Toshitaka Shin, Satoshi Fukasawa et al. · Japanese Journal of Clinical Oncology · 2020 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors

Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto et al. · Cancer Chemotherapy and Pharmacology · 2012 · 30 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Effect of Antimicrobial Prophylaxis Duration on Health Care–Associated Infections After Clean Orthopedic Surgery

Kosei Nagata, Kôji Yamada, Tomohiro Shinozaki et al. · JAMA Network Open · 2022 · 30 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study

Hiroji Uemura, Takefumi Satoh, Hideyasu Tsumura et al. · Prostate International · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

Toshihiko Doi, Atsushi Ohtsu, Nozomu Fuse et al. · Cancer Chemotherapy and Pharmacology · 2012 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16